Clinical Trial Update: Effects on Microcirculation of IgGAM in Severe Septic/Septic Shock Patients. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effects of IgGAM on microcirculation in patients with sepsis and septic shock has completed. The study was sponsored by Università …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• IgGAM (intravenous immunoglobulin G/A/M preparation)

Snippet

Sponsor: Università Politecnica delle Marche | Conditions: Severe Sepsis, Septic Shock | Phase 2 | Status: COMPLETED